Sort
17,288 grants matching “multiple sclerosis”
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
$1,270,249Peter A Calabresi · Johns Hopkins University · U01 · FY2022 · NS
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$1,270,117John Barker Harley · Cincinnati Childrens Hosp Med Ctr · U01 · FY2019 · AI
T Cell Vaccination: A Clinical Trial for MS
$1,269,822University Of Southern California · M01 · FY2004 · RR
Nervous System Development and Plasticity
$1,266,256Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Tissue Injury and Inflammation in Multiple Sclerosis
$1,264,874Cleveland Clinic Lerner Col/Med-Cwru · P01 · FY2005 · NS
Functions and Mechanisms of NF-kB Factors and their Regulators
$1,264,066Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
$1,262,170Peter A Calabresi · Johns Hopkins University · U01 · FY2023 · NS
Center for Mesoscale Mapping
$1,259,600Bruce R Rosen · Massachusetts General Hospital · P41 · FY2024 · EB
Center for Mesoscale Mapping
$1,259,600Bruce R Rosen · Massachusetts General Hospital · P41 · FY2023 · EB
Center for Mesoscale Mapping
$1,259,600Bruce R Rosen · Massachusetts General Hospital · P41 · FY2022 · EB
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,258,255Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Molecular motors in cell biology
$1,257,928Yale E Goldman · University Of Pennsylvania · P01 · FY2009 · GM
Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)
$1,256,883Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2013 · NS
Functions and Mechanisms of NF-kB Factors and their Regulators
$1,255,030Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,252,899Robert J Gropler · Washington University · P41 · FY2022 · EB
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)
$1,250,000Stephanie J Lee · Fred Hutchinson Cancer Research Center · U54 · FY2009 · AI
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
$1,250,000Ashkan Vaziri · Biosensics, Llc · R44 · FY2022 · AG
Organ Specific Project
$1,250,000Dhruv Singhal · Beth Israel Deaconess Medical Center · U54 · FY2022 · HL
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)
$1,250,000Stephanie J Lee · Fred Hutchinson Cancer Research Center · U54 · FY2012 · CA
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,248,280Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
From therapeutic mechanisms to unraveling the pathophysiology of MS
$1,248,280Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Sustained Delivery of Tizanidine for Maintenance Treatment of Moderate to Severe Spasticity
$1,246,488Gregory Watkins · Delpor, Inc. · R44 · FY2022 · NS
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
$1,246,364Ashkan Vaziri · Biosensics, Llc · R44 · FY2023 · AG
PATHOGENESIS AND TREATMENT OF MULTIPLE SCLEROSIS
$1,246,238Yeshiva University · P50 · FY2003 · NS
PATHOGENESIS AND TREATMENT OF MULTIPLE SCLEROSIS
$1,246,238Albert Einstein Col Of Med Yeshiva Univ · P50 · FY2004 · NS